 | • レポートコード：MRC2Q12-19063 • 出版社/出版日：QYResearch / 2022年12月 • レポート形態：英文、PDF、110ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医薬品＆医療 |
| Single User | ￥735,000 (USD4,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,470,000 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 新型コロナウイルス感染症とロシア・ウクライナ戦争の影響により、フォシノプリルナトリウムのグローバル市場は 2022にxxxドルと推定され、2028年までにxxxドルの規模に達し、2022年から2028年の予測期間中にxxx%のCAGRで成長すると予測されています。 フォシノプリルナトリウムのアメリカ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 フォシノプリルナトリウムの中国市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 フォシノプリルナトリウムのヨーロッパ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 生産面において、本レポートは2017年から2022年までのフォシノプリルナトリウムの生産、成長率、メーカー別市場シェア、地域別市場シェア、および2028年までの予測を調査しています。販売面において、本レポートは2017年から2022年までの地域別、企業別、タイプ別、アプリケーション別のフォシノプリルナトリウムの売上および2028年までの予測に焦点を当てています。 フォシノプリルナトリウムのグローバル主要企業には、Huahai Pharma、Sino Pharma、Warrant、Viatris、ANI Pharma、Apotex、Aurobindo Pharma、Bristol Myers Squibb、Chartwell Pharma、DOC Generici、Emcure Pharma、Cipla、Menarini、MS Pharma、Pharmascienceなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 フォシノプリルナトリウム市場は、タイプとアプリケーションによって区分されます。世界のフォシノプリルナトリウム市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別およびアプリケーション別の販売量、売上、予測に焦点を当てています。 【タイプ別セグメント】 錠剤、カプセル 【アプリケーション別セグメント】 高血圧、慢性心不全 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - フォシノプリルナトリウム製品概要 - タイプ別市場（錠剤、カプセル） - アプリケーション別市場（高血圧、慢性心不全） - 調査の目的 ・エグゼクティブサマリー - 世界のフォシノプリルナトリウム販売量予測2017-2028 - 世界のフォシノプリルナトリウム売上予測2017-2028 - フォシノプリルナトリウムの地域別販売量 - フォシノプリルナトリウムの地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別フォシノプリルナトリウム販売量 - 主要メーカー別フォシノプリルナトリウム売上 - 主要メーカー別フォシノプリルナトリウム価格 - 競争状況の分析 - 企業M&A動向 ・タイプ別市場規模（錠剤、カプセル） - フォシノプリルナトリウムのタイプ別販売量 - フォシノプリルナトリウムのタイプ別売上 - フォシノプリルナトリウムのタイプ別価格 ・アプリケーション別市場規模（高血圧、慢性心不全） - フォシノプリルナトリウムのアプリケーション別販売量 - フォシノプリルナトリウムのアプリケーション別売上 - フォシノプリルナトリウムのアプリケーション別価格 ・北米市場 - 北米のフォシノプリルナトリウム市場規模（タイプ別、アプリケーション別） - 主要国別のフォシノプリルナトリウム市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパのフォシノプリルナトリウム市場規模（タイプ別、アプリケーション別） - 主要国別のフォシノプリルナトリウム市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋のフォシノプリルナトリウム市場規模（タイプ別、アプリケーション別） - 主要国別のフォシノプリルナトリウム市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米のフォシノプリルナトリウム市場規模（タイプ別、アプリケーション別） - 主要国別のフォシノプリルナトリウム市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカのフォシノプリルナトリウム市場規模（タイプ別、アプリケーション別） - 主要国別のフォシノプリルナトリウム市場規模（トルコ、サウジアラビア） ・企業情報 Huahai Pharma、Sino Pharma、Warrant、Viatris、ANI Pharma、Apotex、Aurobindo Pharma、Bristol Myers Squibb、Chartwell Pharma、DOC Generici、Emcure Pharma、Cipla、Menarini、MS Pharma、Pharmascience ・産業チェーン及び販売チャネル分析 - フォシノプリルナトリウムの産業チェーン分析 - フォシノプリルナトリウムの原材料 - フォシノプリルナトリウムの生産プロセス - フォシノプリルナトリウムの販売及びマーケティング - フォシノプリルナトリウムの主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - フォシノプリルナトリウムの産業動向 - フォシノプリルナトリウムのマーケットドライバー - フォシノプリルナトリウムの課題 - フォシノプリルナトリウムの阻害要因 ・主な調査結果 |
Fosinopril is an angiotensin converting enzyme (ACE) inhibitor[1] used for the treatment of hypertension and some types of chronic heart failure.
Report Overview
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Product Name estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.
The USA market for Fosinopril Sodium is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The China market for Fosinopril Sodium is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The Europe market for Fosinopril Sodium is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The global key manufacturers of Fosinopril Sodium include Huahai Pharma, Sino Pharma, Warrant, Viatris, ANI Pharma, Apotex, Aurobindo Pharma, Bristol Myers Squibb and Chartwell Pharma, etc. In 2021, the global top five players had a share approximately % in terms of revenue.
Report Scope
This latest report researches the industry structure, sales, revenue, price and gross margin. Major producers’ production locations, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Fosinopril Sodium manufacturers, distributors, end users, industry associations, governments’ industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional Fosinopril Sodium market. Further, it explains the major drivers and regional dynamics of the global Fosinopril Sodium market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable sales, revenue, price, market share and rank data of the manufacturers for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
Huahai Pharma
Sino Pharma
Warrant
Viatris
ANI Pharma
Apotex
Aurobindo Pharma
Bristol Myers Squibb
Chartwell Pharma
DOC Generici
Emcure Pharma
Cipla
Menarini
MS Pharma
Pharmascience
Market Segments
This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides sales, revenue and average price forecast data by age form and by application segments based on sales, price, and value for the period 2017-2028.
Fosinopril Sodium Segment Dosage Form
Tablets
Capsule
Fosinopril Sodium Segment by Application
Hypertension
Chronic heart Failure
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value and sales data of each region and country for the period 2017-2028.
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Fosinopril Sodium market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Report Includes:
This report presents an overview of global market for Fosinopril Sodium, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2017 – 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of Fosinopril Sodium, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Fosinopril Sodium, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Fosinopril Sodium sales, revenue, market share and industry ranking of main manufacturers, data from 2017 to 2022. Identification of the major stakeholders in the global Fosinopril Sodium market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, sales, revenue, and price, from 2017 to 2028. Evaluation and forecast the market size for Fosinopril Sodium sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Huahai Pharma, Sino Pharma, Warrant, Viatris, ANI Pharma, Apotex, Aurobindo Pharma, Bristol Myers Squibb and Chartwell Pharma, etc.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Fosinopril Sodium in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Fosinopril Sodium manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments according to product types, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by age form, by application and by country, sales and revenue for each segment.
Chapter 7: Europe by age form, by application and by country, sales and revenue for each segment.
Chapter 8: Asia Pacific by age form, by application and by country, sales and revenue for each segment.
Chapter 9: Latin America by age form, by application and by country, sales and revenue for each segment.
Chapter 10: Middle East and Africa by age form, by application and by country, sales and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Fosinopril Sodium sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
1 Study Coverage
1.1 Fosinopril Sodium Product Introduction
1.2 Market Dosage Form
1.2.1 Global Fosinopril Sodium Market Size Growth Rate Dosage Form, 2017 VS 2021 VS 2028
1.2.2 Tablets
1.2.3 Capsule
1.3 Market by Application
1.3.1 Global Fosinopril Sodium Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hypertension
1.3.3 Chronic heart Failure
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Fosinopril Sodium Sales Estimates and Forecasts 2017-2028
2.2 Global Fosinopril Sodium Revenue Estimates and Forecasts 2017-2028
2.3 Global Fosinopril Sodium Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Fosinopril Sodium Sales by Region
2.4.1 Global Fosinopril Sodium Sales by Region (2017-2022)
2.4.2 Global Sales Fosinopril Sodium by Region (2023-2028)
2.5 Global Fosinopril Sodium Revenue by Region
2.5.1 Global Fosinopril Sodium Revenue by Region (2017-2022)
2.5.2 Global Fosinopril Sodium Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Fosinopril Sodium Sales by Manufacturers
3.1.1 Global Top Fosinopril Sodium Manufacturers by Sales (2017-2022)
3.1.2 Global Fosinopril Sodium Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Fosinopril Sodium in 2021
3.2 Global Fosinopril Sodium Revenue by Manufacturers
3.2.1 Global Fosinopril Sodium Revenue by Manufacturers (2017-2022)
3.2.2 Global Fosinopril Sodium Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Fosinopril Sodium Revenue in 2021
3.3 Global Fosinopril Sodium Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Fosinopril Sodium Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Fosinopril Sodium Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size Dosage Form
4.1 Global Fosinopril Sodium Sales Dosage Form
4.1.1 Global Fosinopril Sodium Historical Sales Dosage Form (2017-2022)
4.1.2 Global Fosinopril Sodium Forecasted Sales Dosage Form (2023-2028)
4.1.3 Global Fosinopril Sodium Sales Market Share Dosage Form (2017-2028)
4.2 Global Fosinopril Sodium Revenue Dosage Form
4.2.1 Global Fosinopril Sodium Historical Revenue Dosage Form (2017-2022)
4.2.2 Global Fosinopril Sodium Forecasted Revenue Dosage Form (2023-2028)
4.2.3 Global Fosinopril Sodium Revenue Market Share Dosage Form (2017-2028)
4.3 Global Fosinopril Sodium Price Dosage Form
4.3.1 Global Fosinopril Sodium Price Dosage Form (2017-2022)
4.3.2 Global Fosinopril Sodium Price Forecast Dosage Form (2023-2028)
5 Market Size by Application
5.1 Global Fosinopril Sodium Sales by Application
5.1.1 Global Fosinopril Sodium Historical Sales by Application (2017-2022)
5.1.2 Global Fosinopril Sodium Forecasted Sales by Application (2023-2028)
5.1.3 Global Fosinopril Sodium Sales Market Share by Application (2017-2028)
5.2 Global Fosinopril Sodium Revenue by Application
5.2.1 Global Fosinopril Sodium Historical Revenue by Application (2017-2022)
5.2.2 Global Fosinopril Sodium Forecasted Revenue by Application (2023-2028)
5.2.3 Global Fosinopril Sodium Revenue Market Share by Application (2017-2028)
5.3 Global Fosinopril Sodium Price by Application
5.3.1 Global Fosinopril Sodium Price by Application (2017-2022)
5.3.2 Global Fosinopril Sodium Price Forecast by Application (2023-2028)
6 North America
6.1 North America Fosinopril Sodium Market Size Dosage Form
6.1.1 North America Fosinopril Sodium Sales Dosage Form (2017-2028)
6.1.2 North America Fosinopril Sodium Revenue Dosage Form (2017-2028)
6.2 North America Fosinopril Sodium Market Size by Application
6.2.1 North America Fosinopril Sodium Sales by Application (2017-2028)
6.2.2 North America Fosinopril Sodium Revenue by Application (2017-2028)
6.3 North America Fosinopril Sodium Market Size by Country
6.3.1 North America Fosinopril Sodium Sales by Country (2017-2028)
6.3.2 North America Fosinopril Sodium Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Fosinopril Sodium Market Size Dosage Form
7.1.1 Europe Fosinopril Sodium Sales Dosage Form (2017-2028)
7.1.2 Europe Fosinopril Sodium Revenue Dosage Form (2017-2028)
7.2 Europe Fosinopril Sodium Market Size by Application
7.2.1 Europe Fosinopril Sodium Sales by Application (2017-2028)
7.2.2 Europe Fosinopril Sodium Revenue by Application (2017-2028)
7.3 Europe Fosinopril Sodium Market Size by Country
7.3.1 Europe Fosinopril Sodium Sales by Country (2017-2028)
7.3.2 Europe Fosinopril Sodium Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Fosinopril Sodium Market Size Dosage Form
8.1.1 Asia Pacific Fosinopril Sodium Sales Dosage Form (2017-2028)
8.1.2 Asia Pacific Fosinopril Sodium Revenue Dosage Form (2017-2028)
8.2 Asia Pacific Fosinopril Sodium Market Size by Application
8.2.1 Asia Pacific Fosinopril Sodium Sales by Application (2017-2028)
8.2.2 Asia Pacific Fosinopril Sodium Revenue by Application (2017-2028)
8.3 Asia Pacific Fosinopril Sodium Market Size by Region
8.3.1 Asia Pacific Fosinopril Sodium Sales by Region (2017-2028)
8.3.2 Asia Pacific Fosinopril Sodium Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Fosinopril Sodium Market Size Dosage Form
9.1.1 Latin America Fosinopril Sodium Sales Dosage Form (2017-2028)
9.1.2 Latin America Fosinopril Sodium Revenue Dosage Form (2017-2028)
9.2 Latin America Fosinopril Sodium Market Size by Application
9.2.1 Latin America Fosinopril Sodium Sales by Application (2017-2028)
9.2.2 Latin America Fosinopril Sodium Revenue by Application (2017-2028)
9.3 Latin America Fosinopril Sodium Market Size by Country
9.3.1 Latin America Fosinopril Sodium Sales by Country (2017-2028)
9.3.2 Latin America Fosinopril Sodium Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
9.3.6 Colombia
10 Middle East and Africa
10.1 Middle East and Africa Fosinopril Sodium Market Size Dosage Form
10.1.1 Middle East and Africa Fosinopril Sodium Sales Dosage Form (2017-2028)
10.1.2 Middle East and Africa Fosinopril Sodium Revenue Dosage Form (2017-2028)
10.2 Middle East and Africa Fosinopril Sodium Market Size by Application
10.2.1 Middle East and Africa Fosinopril Sodium Sales by Application (2017-2028)
10.2.2 Middle East and Africa Fosinopril Sodium Revenue by Application (2017-2028)
10.3 Middle East and Africa Fosinopril Sodium Market Size by Country
10.3.1 Middle East and Africa Fosinopril Sodium Sales by Country (2017-2028)
10.3.2 Middle East and Africa Fosinopril Sodium Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Huahai Pharma
11.1.1 Huahai Pharma Corporation Information
11.1.2 Huahai Pharma Overview
11.1.3 Huahai Pharma Fosinopril Sodium Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Huahai Pharma Fosinopril Sodium Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Huahai Pharma Recent Developments
11.2 Sino Pharma
11.2.1 Sino Pharma Corporation Information
11.2.2 Sino Pharma Overview
11.2.3 Sino Pharma Fosinopril Sodium Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Sino Pharma Fosinopril Sodium Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Sino Pharma Recent Developments
11.3 Warrant
11.3.1 Warrant Corporation Information
11.3.2 Warrant Overview
11.3.3 Warrant Fosinopril Sodium Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Warrant Fosinopril Sodium Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Warrant Recent Developments
11.4 Viatris
11.4.1 Viatris Corporation Information
11.4.2 Viatris Overview
11.4.3 Viatris Fosinopril Sodium Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Viatris Fosinopril Sodium Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Viatris Recent Developments
11.5 ANI Pharma
11.5.1 ANI Pharma Corporation Information
11.5.2 ANI Pharma Overview
11.5.3 ANI Pharma Fosinopril Sodium Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 ANI Pharma Fosinopril Sodium Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 ANI Pharma Recent Developments
11.6 Apotex
11.6.1 Apotex Corporation Information
11.6.2 Apotex Overview
11.6.3 Apotex Fosinopril Sodium Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Apotex Fosinopril Sodium Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Apotex Recent Developments
11.7 Aurobindo Pharma
11.7.1 Aurobindo Pharma Corporation Information
11.7.2 Aurobindo Pharma Overview
11.7.3 Aurobindo Pharma Fosinopril Sodium Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Aurobindo Pharma Fosinopril Sodium Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Aurobindo Pharma Recent Developments
11.8 Bristol Myers Squibb
11.8.1 Bristol Myers Squibb Corporation Information
11.8.2 Bristol Myers Squibb Overview
11.8.3 Bristol Myers Squibb Fosinopril Sodium Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Bristol Myers Squibb Fosinopril Sodium Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Bristol Myers Squibb Recent Developments
11.9 Chartwell Pharma
11.9.1 Chartwell Pharma Corporation Information
11.9.2 Chartwell Pharma Overview
11.9.3 Chartwell Pharma Fosinopril Sodium Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Chartwell Pharma Fosinopril Sodium Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Chartwell Pharma Recent Developments
11.10 DOC Generici
11.10.1 DOC Generici Corporation Information
11.10.2 DOC Generici Overview
11.10.3 DOC Generici Fosinopril Sodium Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 DOC Generici Fosinopril Sodium Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 DOC Generici Recent Developments
11.11 Emcure Pharma
11.11.1 Emcure Pharma Corporation Information
11.11.2 Emcure Pharma Overview
11.11.3 Emcure Pharma Fosinopril Sodium Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Emcure Pharma Fosinopril Sodium Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Emcure Pharma Recent Developments
11.12 Cipla
11.12.1 Cipla Corporation Information
11.12.2 Cipla Overview
11.12.3 Cipla Fosinopril Sodium Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Cipla Fosinopril Sodium Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Cipla Recent Developments
11.13 Menarini
11.13.1 Menarini Corporation Information
11.13.2 Menarini Overview
11.13.3 Menarini Fosinopril Sodium Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Menarini Fosinopril Sodium Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Menarini Recent Developments
11.14 MS Pharma
11.14.1 MS Pharma Corporation Information
11.14.2 MS Pharma Overview
11.14.3 MS Pharma Fosinopril Sodium Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 MS Pharma Fosinopril Sodium Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 MS Pharma Recent Developments
11.15 Pharmascience
11.15.1 Pharmascience Corporation Information
11.15.2 Pharmascience Overview
11.15.3 Pharmascience Fosinopril Sodium Sales, Price, Revenue and Gross Margin (2017-2022)
11.15.4 Pharmascience Fosinopril Sodium Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Pharmascience Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Fosinopril Sodium Industry Chain Analysis
12.2 Fosinopril Sodium Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Fosinopril Sodium Production Mode & Process
12.4 Fosinopril Sodium Sales and Marketing
12.4.1 Fosinopril Sodium Sales Channels
12.4.2 Fosinopril Sodium Distributors
12.5 Fosinopril Sodium Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Fosinopril Sodium Industry Trends
13.2 Fosinopril Sodium Market Drivers
13.3 Fosinopril Sodium Market Challenges
13.4 Fosinopril Sodium Market Restraints
14 Key Findings in The Global Fosinopril Sodium Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer